| Mepha Pharma AG - Co-Amoxi-Mepha 312,5, Pulver zur Herstellung einer Suspension zum Einneh | | 53982 | | 02 | | Co-Amoxi-Mepha 312,5 | | Pulver zur Herstellung einer Suspension zum Einneh | | J01CR02 | | Amoxicillin and Beta-Lactamase Inhibitor | | 10.03.2000 | | |
| | Composition | | amoxicillinum anhydricum 250 mg ut amoxicillinum trihydricum, acidum clavulanicum 62.5 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aspartamum 16.64 mg, aromatica (Erdbeer) cum alcohol benzylicus et propylenglycolum, ad pulverem corresp. suspensio reconstituta 5 ml corresp. natrium max. 4.7 mg. | | Packungsbestandteile | | | | | | | | | | Active Agent | Dose |
|---|
| Clavulanic Acid | 62.5 mg | | Amoxicillin Anhydride | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Clavulanic Acid | 62.5 mg | | Amoxicillin Anhydride | 250 mg |
| | | | Inactive agents | Dose |
|---|
| | | | Aspartame | 16.64 mg | | Carmellose Sodium | | | | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 100 ml | 11.35 | 28.75 | A | SL | No |
|
|
